RNA interference (RNAi) Product description This project pipeline list provides a competitor analysis of corporate R&D projects in the field of RNA interference such as small interference RNA ( siRNA ) and locked nucleic acid RNA (LNA RNA) projects as of May 2006. The pipeline list contains an abstract summarizing the most important findings and conclusions of the competitor evaluation. Competitor projects are listed in a tabular format on fifteen pages. Information is provided on: - Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Therapeutic Area,
- Indication,
- R&D Stage and additional comments with a hyperlink leading to the source of information.
Index - Clinical RNAi Pipeline
- Preclinical RNAi Pipeline
- Research RNAi Pipeline
- RNAi Company Pipelines
- Acuity Pharmaceuticals
- Alnylam Pharmaceuticals
- Benitec
- CytRx Laboratories
- Nastech Pharmaceuticals
- Santaris Pharma
- Sirna Therapeutics
- SR Pharma
- RNAi Delivery & Protection Technologies
- About La Merie Business Intelligence
About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. Competitor analysis reports can be purchased as individual products or obtained by subscribing to R&D Pipeline News. R&D Pipeline News is published weekly 50-times a year and each issue contains at least two competitor evaluations. Individual products from the Competitor Analysis Series and R&D Pipeline News are independently elaborated by analysts of La Merie Business Intelligence and distributed by PipelineReview.com.
|
